4 completed. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Completed 2 |
Follow Chemi S.p.A.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Extended-release of Octreotide (LF-PB) for the Treatment of Seroma extended release of octreotide, extended release of placebo - Seroma | Phase 2 | Completed | Chemi S.p.A. | 48 | 2015-10-22 | 2017-02-02 |
| Bioavailability Study of Enoxaparin Sodium Chemi and Clexane s.c. Enoxaparin Sodium - Enoxaparin Sodium is Administered to Healthy Volunteers | Phase 1 | Completed | Chemi S.p.A. | 47 | 2014-08-04 | 2020-10-20 |
| A Single-Dose Trial to Examine the Within Subject Variability of Clexane® in Healthy Adults Under Fasting Conditions Enoxaparin sodium - Clexane is Administered to Healthy Volunteers | Phase 1 | Completed | Chemi S.p.A. | 14 | 2014-03-01 | 2020-11-12 |
| Extended-release of Octreotide (LF-PB) for the Treatment of Lymphorrhea LF-PB and Placebo, Placebo, LF-PB - Lymphorrhea | Phase 2 | Completed | Chemi S.p.A. | 114 | 2012-11-01 | 2014-07-29 |
Seroma (1)
Enoxaparin (2) · enoxaparin sodium (2)
Italy (2) · United Kingdom (2)
Paolo Bettica, MD (2) · Paolo Carcoforo, MD (1) · Paolo Carcoforo, Prof. (1)